Cephalon Overview
- Year Founded
-
1987
- Status
-
Acquired/Merged
- Employees
-
800
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$6.8B
Cephalon General Information
Description
Developer of pharmaceuticals intended to treat diseases related to central nervous system, oncology and inflammatory diseases. The company's research, development, manufacturing, and marketing activities focused on therapies for central nervous system disorders, cancer, pain and inflammatory disease.
Contact Information
Website
www.cephalon.comCorporate Office
- 41 Moores Road
- Frazer
- Malvern, PA 19355
- United States
Corporate Office
- 41 Moores Road
- Frazer
- Malvern, PA 19355
- United States
Cephalon Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 14-Oct-2011 | $6.8B | Completed | Generating Revenue | ||
| 3. Merger/Acquisition | 05-Apr-2011 | Cancelled | Generating Revenue | |||
| 2. IPO | 25-Apr-1991 | Completed | Generating Revenue | |||
| 1. Early Stage VC | Completed | Startup |
Cephalon Patents
Cephalon Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2011146488-A1 | Method for purifying a fused pyrrolocarbazole derivative | Inactive | 18-May-2010 | ||
| JP-2013526573-A | Method for purifying molten pyrrolocarbazole derivatives | Active | 18-May-2010 | ||
| WO-2011086194-A1 | Improved oral lysophilisates containing pvp/va | Inactive | 18-Jan-2010 | ||
| EP-2359812-A1 | Oral lyophilised compositions | Inactive | 18-Jan-2010 | ||
| WO-2011086193-A1 | Oral lyophilized compositions | Inactive | 18-Jan-2010 | A61K9/0056 |
Cephalon Signals
Cephalon Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ben Franklin Technology Partners of Southeastern Pennsylvania | Accelerator/Incubator | Minority | ||
| InterWest Partners | Venture Capital | Minority | ||
| New Leaf Venture | Venture Capital | Minority | ||
| New Science Ventures | Venture Capital | Minority | ||
| Oak Investment Partners | Venture Capital | Minority |
Cephalon Investments & Acquisitions (21)
Cephalon’s most recent deal was a Later Stage VC with JSK Therapeutics for . The deal was made on 11-Dec-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| JSK Therapeutics | 11-Dec-2017 | Later Stage VC | Drug Discovery | ||
| Fachklinik Osterhofen | 10-Jan-2012 | Merger/Acquisition | Clinics/Outpatient Services | ||
| Gemin X Pharmaceuticals | 01-Apr-2011 | Merger/Acquisition | Drug Discovery | ||
| Chemgenex Pharmaceuticals | 29-Mar-2011 | Merger/Acquisition | Biotechnology | ||
| Mesoblast | 11-Feb-2011 | PIPE | Drug Discovery |
Cephalon Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Fachklinik Osterhofen | Osterhofen, Germany | 1999 | |
| Mepha | Basel, Switzerland | 1949 |
Cephalon FAQs
-
When was Cephalon founded?
Cephalon was founded in 1987.
-
Where is Cephalon headquartered?
Cephalon is headquartered in Malvern, PA.
-
What is the size of Cephalon?
Cephalon has 800 total employees.
-
What industry is Cephalon in?
Cephalon’s primary industry is Pharmaceuticals.
-
Is Cephalon a private or public company?
Cephalon is a Private company.
-
What is the current valuation of Cephalon?
The current valuation of Cephalon is .
-
What is Cephalon’s current revenue?
The current revenue for Cephalon is .
-
Who are Cephalon’s investors?
Ben Franklin Technology Partners of Southeastern Pennsylvania, InterWest Partners, New Leaf Venture, New Science Ventures, and Oak Investment Partners are 5 of 7 investors who have invested in Cephalon.
-
When was Cephalon acquired?
Cephalon was acquired on 14-Oct-2011.
-
Who acquired Cephalon?
Cephalon was acquired by Teva Pharmaceutical Industries.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process